Volume 18, Number 9—September 2012
Research
Trends in Meningococcal Disease in the United States Military, 1971–2010
Michael P. Broderick
, Dennis J. Faix, Christian J. Hansen, and Patrick J. Blair
, Dennis J. Faix, Christian J. Hansen, and Patrick J. Blair
Table 1
Confirmed and probable cases of meningococcal disease among members of the United States military, 2006–2010*
| Case no. | Year | Q | Death | Clinical syndromes | Military branch | Patient age group, y/sex | Patient race/ ethnicity | Patient military status | Vaccine type | Months from vaccination to illness | Neisseria meningitidis serogroup |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2006 | 1 | Yes | Men, sep | A | 20–24/M | B | AD | MPSV-4 | 12 | C |
| 2 | 2006 | 1 | No | Men | M | 17–19/M | W | AD | MPSV-4 | 7 | C |
| 3 | 2006 | 3 | No | Men | M | 20–24/M | W | Trainee | MPSV-4 | NA | UNK |
| 4 | 2006 | 3 | No | Men, sep | A | 17–19/M | W | Trainee | MPSV-4 | 1 | C |
| 5 | 2006 | 3 | No | Men | M | 17–19/M | W | Trainee | NA | 1 | UNK |
| 6 | 2006 | 4 | No | Men | M | 20–24/M | W | AD | MPSV-4 | 7 | C |
| 7 | 2007 | 3 | No | Men | N | 25–29/M | W | AD | NA | NA | UNK |
| 8 | 2007 | 3 | Yes | Sep | A | 25–29/M | W | AD | MPSV-4 | 62 | B |
| 9 | 2007 | 3 | No | Sep | CG | 35–39/M | UNK | AD | MPSV-4 | 229 | B |
| 10 | 2007 | 3 | Yes | Sep | A | 17–19/M | W | AD | MCV-4 | 3 | C |
| 11 | 2007 | 4 | No | Sep | N | 17–19/M | B | AD | NA | NA | Y |
| 12 | 2008 | 1 | No | Sep | M | 17–19/M | B | Trainee | MPSV-4 | 3 | Y |
| 13 | 2008 | 1 | No | Men | M | 17–19/M | W | AD | MPSV-4 | 5 | Y |
| 14 | 2008 | 1 | No | Men | M | 17–19/M | W | Trainee | MCV-4 | 2 | B |
| 15 | 2008 | 2 | No | Men | M | 17–19/M | W | AD | MCV-4 | 9 | UNK |
| 16 | 2008 | 2 | No | Men, sep | M | 17–19/M | W | Trainee | MCV-4 | 1 | B |
| 17† | 2008 | 3 | Yes | Sep | AF | 35–39/F | A | AD | MPSV-4 | 161 | B |
| 18 | 2008 | 4 | No | Sep | M | 20–24/M | H | Trainee | MCV-4 | 1 | Y |
| 19 | 2008 | 4 | Yes | Men, sep | N | 20–24/M | W | Cadet | MPSV-4 | 15 | Y |
| 20 | 2009 | 1 | No | Men, sep | N | 20–24/M | W | AD | MCV-4 | 4 | Y |
| 21 | 2009 | 1 | No | Men | A | 20–24/F | UNK | AD | MCV-4 | 7 | B |
| 22 | 2010 | 1 | No | Sep | M | 20–24/M | B | Trainee | MCV-4 | 1 | Y |
| 23 | 2010 | 2 | No | Men, sep | N | 20–24/F | W | AD | MPSV-4 | 43 | Y |
| 24 | 2010 | 3 | No | Men, sep | M | 17–19/M | W | Trainee | MCV-4 | 3 | Y |
| 25 | 2010 | 3 | No | Men | M | 25–29/F | B | AD | MCV-4 | 8 | C |
| 26 | 2010 | 4 | No | Men | AF | 20–24/M | B | AD | MCV-4 | 7 | C |
*Q, quarter; men, meningitis; sep, sepsis; A, Army; B, black; AD, active duty; MPSV-4, polysaccharide; M, Marine Corps; W, white; NA, not available (highly unlikely that person was not vaccinated, but vaccination cannot be confirmed); UNK, unknown; CG, Coast Guard; MCV-4, conjugate; N, Navy; AF, Air Force; A, Asian; H, Hispanic/Latino.
†Probable case.
Page created: August 15, 2012
Page updated: August 15, 2012
Page reviewed: August 15, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.